Posted: 28th November 2019
We're proud to announce that SVI Director, Professor Tom Kay, has been appointed to the Australian Association of Medical Research Institute (AAMRI) Board.
The Association is the peak body for medical research institutes across Australia and has 54 member organisations that work across a broad spectrum of human health issues such as preventive health, chronic disease, mental health, immunology and Indigenous health. Their research ranges from fundamental biomedical discovery through to clinical research and the translation of research findings from bench to bedside. In 2018 AAMRI celebrated 25 years of achievements and milestones.
In addition to Tom’s role at SVI and AAMRI, he is also Executive Director of the Aikenhead Centre for Medical Discovery and continues an active role in SVI’s type 1 diabetes research group. As an endocrinologist and clinical immunologist Tom leads the Victorian node of the Australian Islet Transplant Consortium. His research interests include immune mechanisms by which insulin-pproducing beta cells are destroyed in diabetes and proinsulin-specific immune tolerance.
Tom is an Honorary Professorial Fellow at The University of Melbourne, an Honorary Endocrinologist at St Vincent’s Hospital Melbourne and an Honorary Visiting Professor, at the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Professor Kay has been a Fellow of the Australian Academy of Health and Medical Sciences since 2016.
Tom’s insights and experience will be a great contribution to AAMRI.